Previous 10 |
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Rise and shine! It’s time for another breakdown of the biggest pre-market stock movers as we prepare for the opening bell on Wednesday! Source: f11photo/Shutterstock.com News moving stocks this morning includ...
On Tuesday, TC Biopharm (NASDAQ:TCBP), a U.K.-based clinical-stage biotech, announced interim data from its Phase 1a/2b trial for TCB-002, OmnImmune in relapse/ refractory acute myeloid leukemia ("AML"). An experimental allogeneic cell therapy OmnImmune contains unmodified gamma delta T cells...
TC BioPharm Announces Positive Phase 1b/2a Data in Late-Stage Acute Myeloid Leukemia Patients Treated with Allogeneic Gamma Delta T Cells -Complete and near complete responses (morphologic leukemia-free state) observed with OmnImmune® starting at lowest dose level in Phase ...
TC Biopharm to Host Corporate Update Call on March 8th PR Newswire EDINBURGH, Scotland , March 2, 2022 /PRNewswire/ -- TC Biopharm (Holdings) PLC ("TC Biopharm" or the "Company") (NASDAQ: TCBP) (NASDAQ: TCBPW), a clinical stage biotechnology company developi...
TC Biopharm (NASDAQ: TCBP) , a clinical-stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer and viral indications, announced that it has closed on a previously announced initial public offering. The offering comprised more than 4 million A...
TC Biopharm Announces Appointment of New Board Members PR Newswire EDINBURGH, Scotland , Feb. 22, 2022 /PRNewswire/ -- TC Biopharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) (NASDAQ: TCBPW), a clinical stage biotechnology company developi...
News, Short Squeeze, Breakout and More Instantly...
TC BioPharm (Holdings) plc Company Name:
TCBP Stock Symbol:
NASDAQ Market:
TC BioPharm (Holdings) plc Website:
TCBP Announces Dosing of 6th Patient in ACHIEVE Study in Patients with Acute Myeloid Leukemia PR Newswire 5 patients treated in "safety cohort" showed no drug related Serious Adverse Events Restart of trial after amendment approved by MHRA to increase dose level ...
TCBP Announces Launch of Compassionate Use Program for TCB008 PR Newswire The Company's lead therapeutic will be available through a newly opened compassionate use program EDINBURGH, Scotland , May 15, 2024 /PRNewswire/ -- TC BioPharm (Holdings) PLC ...
2024-05-07 06:02:00 ET 3 Tips for Buying and Selling Penny Stocks During After Hours Trading penny stocks during after-hours sessions offers unique opportunities for investors seeking to capitalize on market movements outside of standard trading hours. Penny stocks , typically price...